Hjem › Krampeanfald › Florida
Krampeanfald kliniske forsøg i Florida
16 studier for Krampeanfald søger deltagere på steder i Florida.
Byer i Florida
Officiel studietekst (engelsk)
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
- University of Miami Miller School of Medicine, Miami
- AdventHealth Innovation Tower, Orlando
RekruttererFase 3
Alder 2 til 55 · Alle køn · Opdateret 2. okt. 2026 · NCT05066217A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
- University of South Florida, Tampa
RekruttererFase 1
Alder 12 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT07233239RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
- Northwest Florida Clinical Research Group, LLC, Gulf Breeze
- Ilumina Medical Research, Kissimmee
- Visionary Investigators Network, Miami
- og 3 flere
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 1. okt. 2026 · NCT06798896Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
- Panhandle Research and Medical Clinic, LLC, Gulf Breeze
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 1. okt. 2026 · NCT07563881Optimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and Wearables
- Mayo Clinic, Jacksonville
RekruttererTidlig fase 1Nævner betaling til deltagere
Alder 18 til 75 · Alle køn · Opdateret 25. sep. 2026 · NCT07012148Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- University of Florida, Gainesville
Rekrutterer
Op til 50 år · Alle køn · Opdateret 17. sep. 2026 · NCT02216500A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
- Pediatric Neurology and Epilepsy Specialists, Winter Park
RekruttererFase 3
Alder 2 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT04462770Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
- K2 Medical Research, Maitland
- Serenity Research Center, LLC, Miami
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 2. sep. 2026 · NCT07594119Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
- University of Miami, Miami
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 9. jun. 2026 · NCT05135091AI-Based Mobile Intervention on Medication Non-Adherence and Transition
- Orlando Health Arnold Palmer Hospital, Orlando
- Orlando Health Orlando Regional Medical Center, Orlando
Rekrutterer
Alder 14 til 24 · Alle køn · Opdateret 29. maj 2026 · NCT07445074A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Panhandle Research and Medical Clinic, Gulf Breeze
- Mayo Clinic Florida, Jacksonville
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 14. maj 2026 · NCT05716100Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy
- Green Leaf Clinical Trials, LLC, Jacksonville
- Visionary Investigators Network, Miami
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 21. apr. 2026 · NCT05518578Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits
- Miami VA Healthcare System, Miami, FL, Miami
RekruttererFase 4Frivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 20. apr. 2026 · NCT04419272SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures
- Medsol Clinical Research Center, Port Charlotte
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 10. okt. 2025 · NCT07141329Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- Pediatric Epilepsy and Neurology Specialists, Tampa
RekruttererFase 3
Alder 4 til 55 · Alle køn · Opdateret 24. jul. 2025 · NCT05219617An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
- Praxis Research Site, Miami Lakes
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 3. apr. 2025 · NCT06908356Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.